Drugs / Fluzone High-dose (HD)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04484532 | Oct 2017 → Jun 2022 | acute myeloid leukemia, myelodysplastic syndrome | Roswell Park Cancer Institute | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone High-dose (HD) | “Fluzone High-dose (HD)” NCT04484532 ↗ |